EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cholesterol-Lowering Drugs as Potential Antivirals: A Repurposing Approach against Flavivirus Infections

Juan Fidel Osuna-Ramos iD, Carlos Noe Farfan-Morales iD, Carlos Daniel Cordero-Rivera iD, Luis Adrián De Jesús-González iD, José Manuel Reyes-Ruiz iD, Arianna M Hurtado-Monzón iD, Selvin Noé Palacios-Rápalo iD, Ricardo Jiménez-Camacho, Marco Antonio Meraz-Ríos iD, Rosa María Del Ángel iD

Viruses · 28.06.2023 · 15 (7) · 1465

DOI: 10.3390/v15071465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 28.06.2023. Verfasst von Juan Fidel Osuna-Ramos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies (CINVESTAV-IPN), Mexico City 07360, Mexico. Hauptthemen laut MEDLINE: Zika Virus Infection, Zika Virus, Dengue Virus, Flavivirus Infections. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: R.M.D.Á..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Flaviviruses, including Dengue (DENV), Zika (ZIKV), and Yellow Fever (YFV) viruses, represent a significant global health burden. The development of effective antiviral therapies against these viruses is crucial to mitigate their impact. This study investigated the antiviral potential of the cholesterol-lowering drugs atorvastatin and ezetimibe in monotherapy and combination against DENV, ZIKV, and YFV. In vitro results demonstrated a dose-dependent reduction in the percentage of infected cells for both drugs. The combination of atorvastatin and ezetimibe showed a synergistic effect against DENV 2, an additive effect against DENV 4 and ZIKV, and an antagonistic effect against YFV. In AG129 mice infected with DENV 2, monotherapy with atorvastatin or ezetimibe significantly reduced clinical signs and increased survival. However, the combination of both drugs did not significantly affect survival. This study provides valuable insights into the potential of atorvastatin and ezetimibe as antiviral agents against flaviviruses and highlights the need for further investigations into their combined therapeutic effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zika Virus InfectionZika VirusDengue VirusFlavivirus InfectionsFlavivirusDengueAnimalsMiceAntiviral AgentsAtorvastatinDrug RepositioningEzetimibeCholesterol

Stichwörter der Autor:innen

DENVYFVZIKVantiviral agentsatorvastatincholesterol-lowering drugsezetimibeflavivirusessynergistic effecttherapeutic use

Substanzen

Antiviral AgentsAtorvastatinEzetimibeCholesterol

Autor:innen und Institutionen

  • Department of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies (CINVESTAV-IPN), Mexico City 07360, Mexico.
  • Facultad de Medicina, Universidad Autónoma de Sinaloa, Culiacán 80019, Mexico.
  • Departamento de Ciencias Naturales, Universidad Autónoma Metropolitana (UAM), Unidad Cuajimalpa, Mexico City 05348, Mexico.
  • Unidad de Investigación Biomédica de Zacatecas, Instituto Mexicano del Seguro Social, Zacatecas 98000, Mexico.
  • Unidad Médica de Alta Especialidad, Hospital de Especialidades No. 14, Centro Médico Nacional "Adolfo Ruiz Cortines", Instituto Mexicano del Seguro Social (IMSS), Veracruz Norte, Veracruz 91810, Mexico.
  • Facultad de Medicina, Región Veracruz, Universidad Veracruzana (UV), Veracruz 91090, Mexico.

ORCID-Profile: Juan Fidel Osuna-Ramos, Carlos Noe Farfan-Morales, Carlos Daniel Cordero-Rivera, Luis Adrián De Jesús-González, José Manuel Reyes-Ruiz, Arianna M Hurtado-Monzón, Selvin Noé Palacios-Rápalo, Marco Antonio Meraz-Ríos, Rosa María Del Ángel

Förderung

  • R.M.D.Á.

Zitieren

APA

Osuna-Ramos, J. F., Farfan-Morales, C. N., Cordero-Rivera, C. D., De Jesús-González, L. A., Reyes-Ruiz, J. M., Hurtado-Monzón, A. M., Palacios-Rápalo, S. N., Jiménez-Camacho, R., Meraz-Ríos, M. A., & Del Ángel, R. M. (2023). Cholesterol-Lowering Drugs as Potential Antivirals: A Repurposing Approach against Flavivirus Infections. Viruses, 15(7), 1465. https://doi.org/10.3390/v15071465

Vancouver

Osuna-Ramos JF, Farfan-Morales CN, Cordero-Rivera CD, De Jesús-González LA, Reyes-Ruiz JM, Hurtado-Monzón AM, et al. Cholesterol-Lowering Drugs as Potential Antivirals: A Repurposing Approach against Flavivirus Infections. Viruses. 2023;15(7):1465. doi:10.3390/v15071465

BibTeX
@article{OsunaRamos2023,
  author = {Osuna-Ramos, Juan Fidel and Farfan-Morales, Carlos Noe and Cordero-Rivera, Carlos Daniel and De Jesús-González, Luis Adrián and Reyes-Ruiz, José Manuel and Hurtado-Monzón, Arianna M and Palacios-Rápalo, Selvin Noé and Jiménez-Camacho, Ricardo and Meraz-Ríos, Marco Antonio and Del Ángel, Rosa María},
  title = {Cholesterol-Lowering Drugs as Potential Antivirals: A Repurposing Approach against Flavivirus Infections},
  journal = {Viruses},
  year = {2023},
  volume = {15},
  number = {7},
  pages = {1465},
  doi = {10.3390/v15071465}
}
Kostenlos starten →